Incidence and risk factors for anastomotic bleeding in lower gastrointestinal surgery

BMC Research Notes, Jul 2019

Although major anastomotic bleeding after lower gastrointestinal surgery is considered rare, it can be life-threatening if not properly managed. The objective of this study was to assess the incidence of postoperative lower gastrointestinal intraluminal bleeding and to identify its potential risk factors. This retrospective cohort study used data from charts of 314 patients who underwent digestive surgery of the colon or small intestine. Details are reported for their sociodemographic data, surgical approach, comorbidities, timing and presentation of intraluminal bleeding events, bleeding diagnosis, treatment strategies, hospital length of stay, and clinical complications. A total of 7 patients (2.3%) experienced intraluminal bleeding in the postoperative period. The average length of hospital stay before discharge was 12 days (median = 13 days). Patients with intraluminal bleeding had a significantly higher percentage of coronary artery diseases compared to patients without intraluminal bleeding (P value = .04), as well as having a cancer diagnosis (P value = .02). The clinical complications that were more likely in patients with intraluminal bleeding included requiring blood transfusions (P value = .01), reduction in hemoglobin (P value = .001), cardiac ischemia (P value = .02), and atrial fibrillations (P value = .02).

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-019-4403-0

Incidence and risk factors for anastomotic bleeding in lower gastrointestinal surgery

Research note Open Access Incidence and risk factors for anastomotic bleeding in lower gastrointestinal surgery Jocelyne Hébert1, 5, Sherif Eltonsy2, 3, 4Email authorView ORCID ID profile, Jeffrey Gaudet2, 3 and Caroline Jose3, 5 BMC Research Notes201912:378 https://doi.org/10.1186/s13104-019-4403-0 ©  The Author(s) 2019 Received: 3 May 2019Accepted: 24 June 2019Published: 3 July 2019 Abstract Objective Although major anastomotic bleeding after lower gastrointestinal surgery is considered rare, it can be life-threatening if not properly managed. The objective of this study was to assess the incidence of postoperative lower gastrointestinal intraluminal bleeding and to identify its potential risk factors. This retrospective cohort study used data from charts of 314 patients who underwent digestive surgery of the colon or small intestine. Details are reported for their sociodemographic data, surgical approach, comorbidities, timing and presentation of intraluminal bleeding events, bleeding diagnosis, treatment strategies, hospital length of stay, and clinical complications. Results A total of 7 patients (2.3%) experienced intraluminal bleeding in the postoperative period. The average length of hospital stay before discharge was 12 days (median = 13 days). Patients with intraluminal bleeding had a significantly higher percentage of coronary artery diseases compared to patients without intraluminal bleeding (P value = .04), as well as having a cancer diagnosis (P value = .02). The clinical complications that were more likely in patients with intraluminal bleeding included requiring blood transfusions (P value = .01), reduction in hemoglobin (P value = .001), cardiac ischemia (P value = .02), and atrial fibrillations (P value = .02). Keywords Anastomotic bleedingGastrointestinal SurgeryPostoperativeComplicationsHemorrhage Introduction Among the most common lower gastrointestinal anastomosis complications are leakage and dehiscence, strictures, fistulas and bleeding [1, 2]. While risk factors for leakage and dehiscence, strictures and fistulas are widely reported [3–6], risk factors for anastomotic bleeding are not as well known. Most cases of postoperative anastomotic bleeding are self-limiting and are not commonly reported by surgeons, however major anastomotic bleeding can be life-threatening if not treated promptly [7]. The reported incidence rates for severe lower gastrointestinal bleeding range from .5 to 4.2% [8–11]. Severe lower gastrointestinal bleeding can be difficult to locate, making the diagnostic and therapeutic maneuvers challenging [11]. Conservative approaches have been successful in some cases, though only a handful have been reported in the literature [8]. Surgical techniques have evolved quickly, with newer generations of innovative medical and surgical materials being currently employed. Those advances render studies on lower gastrointestinal bleeding prevalence and management strategies relatively outdated, and novel evidence from recent studies become crucial and necessary. Given the scarce evidence in the published literature on the risk factors associated with major anastomotic bleeding, this study aimed at assessing the incidence of postoperative lower gastrointestinal intraluminal bleeding and identifying its potential risk factors. Main text Methods We conducted a single-center retrospective cohort study. The cohort was constructed using data from the reviewed charts of 314 consecutive patients who underwent digestive surgery of the colon or small intestine by six different surgeons. The procedures were performed between December 2009 and December 2014 at the Dr. Georges-L.-Dumont University Hospital Centre, Moncton, New Brunswick, Canada. The study cohort included low rectal anterior resection in 153 patients, right standard/extended hemicolectomy in 102 patients, small bowel resection in 22 patients, Ileocecal resection in 19 patients, partial colectomy in 6 patients, total colectomy and ileorectal anastomosis in 6 patients, and left hemicolectomy in 6 patients. Fifty-six percent of surgeries were performed by laparoscopy or assisted by laparoscopy compared to forty-four percent being open surgeries. The vast majority of anastomosis were fashioned using staples. An end to end type anastomosis was the technic used during all low anterior resections and some partial colectomies while a side to side anastomosis was used for most right hemicolectomies and small bowel resections as well as for a few partial colectomies. An end to side ileorectal anastomosis was most often used for cases of total colectomies. Patients who experienced postoperative intraluminal bleeding were identified, and a comprehensive chart review of their clinical and operative notes was undertaken. Postoperative intraluminal bleeding was defined as a persistent rectorrhagia or melena occurring within 30 postoperative days and associated with a 20 g/L decrease in hemoglobin, and cases were confirmed after thorough medical chart review (Additional file 1: Fig. S1). Details were recorded for the following parameters: sociodemographic data, surgical approach, comorbidities, timing and presentation of intraluminal bleeding event, bleeding diagnosis, treatment strategies, hospital length of stay and clinical complications. Descriptive statistics for the characteristics of patients were calculated and compared between patients with and without intraluminal bleeding. To account for the small sample size of patients with intraluminal bleeding, non-parametric tests, Fisher’s exact or Mann–Whitney U univariate analysis tests, were used to examine the difference for categorical and continuous variables, respectively. We reported the data as means ± standard deviations (SD) and percentages, as well as the calculated P value. A level of P < .05 was considered as statistically significant. Statistical analyses were conducted using SAS software, version 9.4 (SAS Institute Inc., Cary, NC). This study was approved by the Research Ethics Committee of the Vitalité Health Network. Consent to participate was waived, as only retrospective and de-identified data were used. Results The operative morbidity data were reliably available for 309 patients who had undergone digestive surgery of the colon or small intestine and who were finally included in the cohort analysis. Forty-nine percent of patients were women, with an average age of 64 years (SD = 14.2) and average body mass index (BMI) of 28.6 (SD = 6.8). The most commonly used preoperative prophylaxis medications consisted of Heparin prophylaxis (64.1%). Some patients were on antiplatelets (26.2%), and natural products (14.2%) preoperatively. Whereas the most common postoperative medications were Heparin prophylaxis (87.7%), Lovenox (9.4%), antiplatelets (19.1%), and Nonsteroidal Anti-Inflammatory drugs (NSAIDs) (22.9%). A total of 7 (2.3%) patients experienced intraluminal bleeding in the postoperative period (Table 1). Overall, patients with and without intraluminal bleeding were comparable in their sociodemographic and clinical variables measured at admission. Tests of differences between groups confirmed the similarity between groups (i.e. P values ≥ .05), with the exception of two variables. Among the recorded comorbidities, patients with intraluminal bleeding had a significantly higher percentage of coronary artery diseases compared to patients without intraluminal bleeding (P value = .04). Moreover, having a cancer diagnosis as a motive for surgery was significantly higher among patients with intraluminal bleeding (P value = .02). No other differences were found between groups on the following operation related variables: length of hospital stay, difficulties in per-operative, surgical approach and type of mounting. Table 1 Characteristics and univariate analysis of patients with and without intraluminal bleeding included in the analysis Demographics With intraluminal bleeding (n = 7) Without intraluminal bleeding (n = 302) Fisher’s exact or Mann–Whitney U test No. (%) or Mean ± SD No. (%) or Mean ± SD P value Sex (female) 2 (28.6) 148 (49.0) .45 Age (years) 69 ± 7.4 64 ± 14.3 .33 Body Mass Index (BMI) 27.2 ± 3.6 28.6 ± 6.9 .58 Comorbidity  History of cancer 1 (14.3) 45 (14.9) .99  Coronary artery disease 3 (42.9) 34 (11.3) .04  Peripheral vascular disease 0 (0) 24 (7.8) .56  Hypertension 3 (42.9) 139 (46) .99  Previous surgery 2 (28.6) 127 (42.1) .70 Surgery motive  Cancer 7 (100) 169 (55.9) .02  Diverticulosis 0 (0) 55 (18.2) .36  Other 0 (0) 78 (25.8) .20 Surgical approach  Laparoscopic 2 (28.6) 144 (47.6) .45  Laparotomy 3 (42.9) 133 (44.0) .99  Laparoscopy assisted surgery 2 (28.6) 25 (8.3) .12 Italic values indicate significance of the p value (p < 0.05) The characteristics and clinical courses of patients with intraluminal bleeding are presented in Table 2. The average time from primary surgery to intraluminal bleeding was 6 days and ranged from 1 to 10 days, however most of the patients (i.e. 5 patients [71.4%]) had their postoperative bleeding 6 days or more after surgery. Bleeding symptoms included rectorrhagia in 5 patients and melena in the other 2 cases. Four patients needed packed red blood cell transfusions (2, 3, 4 and 6 units) and one patient needed operative treatment. In the six cases of non-operative treatment, clinical and endoscopy investigations were performed to confirm the origin of the bleeding site. Surgery was required for the other patient due to the persistent bleeding and haemodynamic instability. The average length of hospital stay before discharge was 12 days (median = 13 days), ranging between 4 and 26 days. Table 2 Characteristics and clinical courses of patients with intraluminal bleeding Patient Age Gender Diagnosis Primary surgical technique Surgical approach Anastomosis technique* Time to postoperative hemorrhage (days) Bleeding diagnosis Treatment Hospital stay (days) 1 73 M Non-occlusive cancer Total colectomy and ileorectal anastomosis Laparotomy Side to side, mechanical PO #6 Clinical   26 2 81 F Non-occlusive cancer Low rectal anterior resection Laparoscopy assisted End to end, mechanical PO #7 Endoscopic Transfusions (2); 13 3 66 M Non-occlusive cancer Right standard/extended hemicolectomy Laparoscopic Side to side, mechanical PO #1 Clinical Transfusions (3); 14 4 72 M Non-occlusive cancer Right standard/extended hemicolectomy Laparoscopy assisted Side to side, mechanical PO #10 Endoscopic Transfusions (4); 13 5 57 M Cancer (Metastasis melanoma) Small bowel resection Laparotomy Side to side, mechanical PO #10 Radiological Transfusions (6); re-operation 8 6 66 M Cancer (unresectable polyp) Right standard/extended hemicolectomy Laparoscopic Side to side, mechanical PO #3 Clinical   4 7 70 F Non-occlusive cancer Low rectal anterior resection Laparotomy End to end, mechanical PO #7 Clinical   7 PO postoperative * Side to side anastomosis technique: one application of linear cutter stapler on the anti-mesenteric side of both bowel ends and one application of a linear stapler to close the end. End to end anastomosis technique: one application of a circular stapler Several clinical complications were more likely in patients with intraluminal bleeding (Table 3). These complications included a greater likelihood of requiring blood transfusion (P value = .01), experiencing a drop in hemoglobin greater than 20 g/dL (P value = .001), experiencing cardiac ischemia (P value = .02), and suffering an atrial fibrillation (P value = .02). Table 3 Clinical complications among patients with and without intraluminal bleeding   With intraluminal bleeding (n = 7) Without intraluminal bleeding (n = 302) Fisher’s exact or Mann–Whitney U test No. (%) No. (%) P value Transfusion 4 (57.1) 37 (12.3) .01 Decrease in hemoglobin ≥ 20 g/dL 6 (85.7) 32 (10.6) .001 Re-intervention 1 (14.3) 15 (4.9) .31 Wound infection 2 (28.6) 27 (8.9) .13 Cardiac ischemia 2 (28.6) 8 (2.7) .02 Pulmonary overload 1 (14.3) 2 (.66) .07 Atrial fibrillation 2 (28.6) 8 (2.7) .02 Septic shock 1 (14.3) 6 (2.0) .15 Gastroparesis 1 (14.3) 2 (.66) .07 Acute renal failure 1 (14.3) 10 (3.3) .23 Death 0 (0) 9 (2.9) .23 Italic values indicate significance of the p value (p < 0.05) Discussion In this study of patients who underwent digestive surgery of the colon or small intestine, we observed a moderate incidence of intraluminal bleeding in the postoperative period (2.3%) compared to previously published reports [7–9, 12]. Most of the bleeding cases occurred within 6 days postoperatively and patients were hospitalized for 12 days on average before discharge. From the comparison tests conducted, we observed a significantly increased proportion of coronary artery diseases and cancer diagnosis among patients with intraluminal bleeding compared to patients without intraluminal bleeding. Moreover, significant increases in some clinical complications were observed, including blood transfusions, decrease in hemoglobin ≥ 20 g/dL, cardiac ischemia and atrial fibrillations. The published evidence on lower gastrointestinal anastomosis and postoperative bleeding is limited [7–9, 12]. Defining anastomotic hemorrhage as a massive bleeding occurrence that needed endoscopic or surgical intervention, Tanizawa et al. reported an incidence of .4% and a mean of 24 days before discharge [7]. In the study, none of the baseline variables (i.e. age, sex, use of anticoagulants and hemoglobin level) was significantly different between the groups with and without anastomotic hemorrhage [7]. In a study on the risk factors for delayed bleeding after colorectal endoscopic submucosal resection, delayed bleeding occurred in 6.6% of the patients and there was no significant difference between the two groups in mean age, sex and current use of antithrombotic agents [12]. Moreover, the study demonstrated that the lesion location in the rectum was a significant risk factor for delayed bleeding [12]. Severe lower gastrointestinal bleeding was reported also in two case-series studies [8, 9]. The reported incidence of bleeding and median length of hospital stay were .5% and 11 days among 1389 patients [8] and .8% and 7 days among 777 patients [9], respectively. Respecting specific technical details while creating the anastomosis are known to reduce the incidence of anastomotic bleeding [13, 14]. A latero-lateral anastomosis should be fashioned by using the anti-mesenteric borders of the bowel and the stapled GIA line should be inspected for bleeding [14]. On an end-to-end anastomosis, clearing the mesentery from the transected bowel edge reduces the risk of having a major vessel left untied and stapled with the anastomosis. All anastomotic bleeding sites should be ligated with a absorbable stitch and not cauterized [14]. Even when these technical details are respected, major anastomotic bleeding will occur in .5–4.2% of lower gastrointestinal anastomosis [8, 9]. Our study had a 3.4% anastomotic bleeding rate in proximal side to side anastomosis versus a 1.3% rate in end to end anastomosis. Proximal side to side anastomosis are slightly more challenging to approach by endoscopy. There is less visibility with a blood covered bowel and the longer insulation time increases the risk of perforation. Our study could not demonstrate this increase in complication rate with endoscopic treatment, mainly due to the small sample size and the absence of a necessary endoscopic intervention. The primary objective of the current study included the identification of potential risk factors associated with major anastomotic bleeding. We found significantly increased proportions of coronary artery diseases and cancer diagnosis among patients with intraluminal bleeding. Additional analyses using regression models were performed but not reported due to small sample sizes and convergence issues. Future studies are warranted to carefully investigate those two potential risk factors in larger patient populations. Moreover, additional investigations into the observed major complications (i.e. cardiac ischemia and atrial fibrillations) are required to help guide physicians through optimal approaches in managing patients after surgery. Limitations Results of the current study has to be viewed cautiously given the presence of some important limitations that impact the study conclusions. Due to the retrospective and nonrandomized nature of the study, we were unable to reduce bias that could be caused by unmeasured factors. The sample size of the study represents another major limitation. We did not have enough power to report the regression analyses models due to the relative rarity of the outcome of interest (only 7 cases), rendering our models unstable and affecting their validity. We were only able to evaluate the clinical events if they were documented in the chart by the physician; potentially underreporting some clinical events. Although unlikely because of the small community served, we were unable to confirm that no other patient presented with intraluminal bleeding at another hospital since our data predates the provincial electronic health records. Given the mentioned limitations, additional studies are essential to examine if the results of the current study can be corroborated in other cohorts of larger size. Finally, the data were retrieved from one center, affecting the generalizability of our results. Abbreviations SD:  standard deviations BMI:  body mass index NSAIDs:  Nonsteroidal Anti-Inflammatory drugs Declarations Acknowledgements Not applicable. Funding Not applicable. Authors’ contributions JH, JG and CJ have contributed to the concept and design of the study. JG performed the analysis. JH and JG drafted the first draft. JH, JG, CJ and SE participated in the interpretation of the data. JH, JG, CJ and SE contributed in drafting and revising of the full manuscript, and have approved the manuscript as submitted. JH, JG, CJ and SE have met the criteria of authorship, and take public responsibility for the study contents. All authors read and approved the final manuscript. Ethics approval and consent to participate This study was approved by the Research Ethics Committee of the Vitalité Health Network. Consent to participate was waived, as only retrospective and de-identified data were used. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Additional files 13104_2019_4403_MOESM1_ESM.docx Additional file 1: File S1. Cohort selection flowchart. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Authors’ Affiliations (1) Vitalité Health Network, Moncton, Canada (2) Centre de Formation médicale du Nouveau-Brunswick, Moncton, Canada (3) Maritime SPOR SUPPORT Unit, Moncton, Canada (4) College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB, R3E 0T5, Canada (5) Université de Sherbrooke, Quebec City, Canada References Kirchhoff P, Clavien P-A, Hahnloser D. Complications in colorectal surgery: risk factors and preventive strategies. Patient Saf Surg. 2010;4:5. https://doi.org/10.1186/1754-9493-4-5.View ArticlePubMedPubMed CentralGoogle ScholarDavis B, Rivadeneira DE. Complications of colorectal anastomoses. Surg Clin North Am. 2013;93:61–87. https://doi.org/10.1016/j.suc.2012.09.014.View ArticlePubMedGoogle ScholarPaun BC, Cassie S, MacLean AR, Dixon E, Buie WD. postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807–18. https://doi.org/10.1097/SLA.0b013e3181dae4ed.View ArticlePubMedGoogle ScholarSlieker JC, Komen N, Mannaerts GH, Karsten TM, Willemsen P, Murawska M, et al. Long-term and perioperative corticosteroids in anastomotic leakage. Arch Surg. 2012;147:447–52. https://doi.org/10.1001/archsurg.2011.1690.View ArticlePubMedGoogle ScholarFazio VW, Tekkis PP, Remzi F, Lavery IC. Assessment of operative risk in colorectal cancer surgery: the cleveland clinic foundation colorectal cancer model. Dis Colon Rectum. 2004;47:2015–24. https://doi.org/10.1007/s10350-004-0704-y.View ArticlePubMedGoogle ScholarPrystowsky JB, Bordage G, Feinglass JM. Patient outcomes for segmental colon resection according to surgeon’s training, certification, and experience. Surgery. 2002;132:663–70 (discussion 670-2).View ArticleGoogle ScholarTanizawa Y, Bando E, Kawamura T, Tokunaga M, Ono H, Terashima M. Early postoperative anastomotic hemorrhage after gastrectomy for gastric cancer. Gastric Cancer. 2010;13:50–7. https://doi.org/10.1007/s10120-009-0535-6.View ArticlePubMedGoogle ScholarMartínez-Serrano M-A, Parés D, Pera M, Pascual M, Courtier R, Egea MJG, et al. Management of lower gastrointestinal bleeding after colorectal resection and stapled anastomosis. Tech Coloproctol. 2009;13:49–53. https://doi.org/10.1007/s10151-009-0458-6.View ArticlePubMedGoogle ScholarMalik AH, East JE, Buchanan GN, Kennedy RH. Endoscopic haemostasis of staple-line haemorrhage following colorectal resection. Color Dis. 2008;10:616–8. https://doi.org/10.1111/j.1463-1318.2007.01459.x.View ArticleGoogle ScholarNeutzling CB, Lustosa SA, Proenca IM, da Silva EM, Matos D. Stapled versus handsewn methods for colorectal anastomosis surgery. Cochrane Database Syst Rev. 2012;1:1. https://doi.org/10.1002/14651858.cd003144.pub2.View ArticleGoogle ScholarCirocco WC, Golub RW. Endoscopic treatment of postoperative hemorrhage from a stapled colorectal anastomosis. Am Surg. 1995;61:460–3.PubMedGoogle ScholarTerasaki M, Tanaka S, Shigita K, Asayama N, Nishiyama S, Hayashi N, et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal neoplasms. Int J Colorectal Dis. 2014;29:877–82. https://doi.org/10.1007/s00384-014-1901-3.View ArticlePubMedGoogle ScholarBowley D, Kingsnorth A. Fundamentals of surgical practice: a preparation guide for the intercollegiate MRCS examination. 3rd ed. Cambridge: Cambridge University Press; 2011.Google ScholarDietz D, Bailey H. Postoperative complications. In: Church JM, Beck DE, Wolff BG, Fleshman JW, Pemberton J, editors. The ASCRS textbook of colon and rectal surgery. New York: Springer; 2006. p. 141.Google Scholar Copyright © The Author(s) 2019


This is a preview of a remote PDF: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-019-4403-0

Jocelyne Hébert, Sherif Eltonsy, Jeffrey Gaudet, Caroline Jose. Incidence and risk factors for anastomotic bleeding in lower gastrointestinal surgery, BMC Research Notes, 2019, 378, DOI: 10.1186/s13104-019-4403-0